Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.

Pavel M, Hörsch D, Caplin M, Ramage J, Seufferlein T, Valle J, Banks P, Lapuerta P, Sands A, Zambrowicz B, Fleming D, Wiedenmann B.  Journal of Clinical Endocrinology and Metabolism, 2015; 100: 1511-9.

Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors.

Valle JW, Faivre S, Hubner RA, Grande E, Raymond E. Cancer Treatment  Reviews, 2014; 40: 1230-8.

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.

Dobson R, Burgess MI, Valle JW, Pritchard DM, Vora J, Wong C, Chadwick C, Keevi B, Adaway J, Hofmann U, Poston GJ, Cuthbertson DJ. British Journal of Cancer, 2014; 111: 1703-9.

Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique.

Fish R, Selvasekar C, Crichton P, Wilson M, Fulford P, Renehan A, O'Dwyer S. Surgical Endoscopy, 2014; 28: 341-5.

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

Meyer T, Qian W, Caplin ME, Armstrong G, Lao-Sirieix SH, Hardy R, Valle JW, Talbot DC, Cunningham D, Reed N, Shaw A, Navalkissoor S, Luong TV, Corrie PG. European Journal of Cancer, 2014; 50 :902-11. 

A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours.

Valle JW, Eatock M, Clueit B, Gabriel Z, Ferdinand R, Mitchell S. Cancer Treatment Reviews, 2014; 40: 376-89.

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB; UK and Ireland Neuroendocrine Tumour Society. Gut, 2012; 61: 6-32.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P. New England Journal of Medicine, 2011; 364: 501-13.

A 3 year retrospective audit of chromogranin results in a tertiary referral centre: Is Chromogranin B measurement necessary?

Monaghan PJ, Darby D, Valle J, Mansoor W, Trainer PJ. Regulatory Peptides, 2010; 164: 12.

Last updated: October 2021

Christie stories during the COVID-19 pandemic

During the COVID-19 pandemic, we're doing all we can to make sure patients get the treatment, information and support they need. Read some stories from our patients and staff to find out what The Christie is doing at this difficult time.

View All
Corinne Faivre Finn
“We have seen a lot of our research staff return to the office. This has massively improved morale as it is a lot easier to connect with people.”
Corinne Faivre-Finn, Christie consultant
Read More
Read More
profile placeholder image
“The experience has allowed me to be able to hear what is not being said. The extraordinary strength and resilience of individuals as they greet you with a smile… when you are aware of the pain and anguish they will be going through.”
Digital services team, redeployed to telephone patients
Read More
Read More
“Of course, the COVID-19 virus has not gone away – we have to be cautious and we have to proceed in an appropriate way.”
Professor John Radford, director of research at The Christie
Read More
Read More